Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TU-2218 by TiumBio for Colorectal Cancer: Likelihood of Approval
TU-2218 is under clinical development by TiumBio and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase II...
TU-2218 by TiumBio for Cervical Cancer: Likelihood of Approval
TU-2218 is under clinical development by TiumBio and currently in Phase II for Cervical Cancer. According to GlobalData, Phase II...
TU-2218 by TiumBio for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
TU-2218 is under clinical development by TiumBio and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma). According to GlobalData,...